Pharmaceutical News

RSS

Recall of Strength Store-brand Acetaminophen caplets

The U.S. Food and Drug Administration (FDA) is alerting the public to a voluntary recall being conducted by Perrigo Company (Perrigo) of Allegan, Michigan for 383 lots of acetaminophen 500mg caplets manufactured and distributed under various store-brands as a result of small metal fragments found in a small number of these caplets.

13 Nov 2006

Majority of Medicare beneficiaries satisfied with prescription drug plans

Three-fourths of Medicare beneficiaries enrolled in the prescription drug benefit are satisfied with their plans, according to a recent Wall Street Journal Online/Harris Interactive poll, Wall Street Journal Online reports.

8 Nov 2006

Bionomics delivers on milestones for cancer, anxiety and multiple sclerosis programs

Australian drug discovery company Bionomics Limited today updated shareholders at its Annual General Meeting on the recent progress of its anti-cancer drug BNC105 and drug discovery programs in anxiety and Multiple Sclerosis.

8 Nov 2006

Problems with billing for Medicare prescription drug benefit premiums persist

About 50,000 of the 4.7 million Medicare beneficiaries who opted to have their Medicare prescription drug benefit premiums automatically withdrawn from their Social Security checks still are having incorrect amounts deducted, CMS officials said, USA Today reports.

8 Nov 2006

New initiative to combat corruption in medicines procurement

Huge amounts of money - up to $50 billion - are spent every year on pharmaceutical products, a market so large that it is extremely vulnerable to corruption. Recent estimates have shown that as much as 25% of medicines which are procured can be lost to fraud, bribery and other corrupt practices.

30 Oct 2006

GSK about to sign another big bird flu deal

Europe's largest drug maker GlaxoSmithKline is said to be about to sign another deal to provide tens of millions of doses of it's experimental H5N1 vaccine for humans.

30 Oct 2006

Big pharma contributes millions to Republican congressional campaigns in close races

The Wall Street Journal on Wednesday examined how pharmaceutical companies are "pouring millions of dollars" into congressional campaigns in close races, "giving some Republicans a financial edge."

26 Oct 2006

Wal-Mart expands generic prescription drug discount program

Wal-Mart Stores on Thursday announced plans to expand a generic prescription drug discount program introduced last month to 12 additional states, the AP/Houston Chronicle reports (AP/Houston Chronicle, 10/26).

26 Oct 2006

FDA approves Tyzeka for the treatment of adults with chronic hepatitis B

The Food and Drug Administration (FDA) has approved Tyzeka (telbivudine) for the treatment of adults with chronic hepatitis B (HBV), a serious viral infection that attacks the liver and can cause lifelong infection, scarring of the liver (cirrhosis), and eventually liver cancer, liver failure, and death.

26 Oct 2006

Shingles vaccine for seniors gets the green light

A government advisory panel in the United States has given it's backing for a new vaccine against shingles.

26 Oct 2006

Doctors warned that commonly used painkillers linked to increased risk of heart attacks

Doctors in the UK are being warned that commonly used painkillers such as ibuprofen can increase the risk of heart attacks if taken over long periods.

25 Oct 2006

Bristol-Myers Squibb receives FDA approval for new formulation of antiretroviral Reyataz

Bristol-Myers Squibb on Friday announced that it has received FDA approval for a single 300 mg capsule formulation of its protease inhibitor Reyataz to be taken as part of combination therapy, Reuters reports.

24 Oct 2006

Use of subcutaneous injections of Epogen for dialysis patients could save Medicare $537 million annually

Administering the anti-anemia drug Epogen to kidney dialysis patients by subcutaneous injections rather than intravenously could save the federal government hundreds of millions of dollars annually, the Boston Globe reports.

24 Oct 2006

Flu vaccinations in Israel back on

According to Israeli health officials the deaths of four men who had received a flu jab were not connected to the vaccination and the flu vaccination programme will now be resumed.

23 Oct 2006

FDA approves Omnaris, new hay fever drug

The U.S. Food and Drug Administration (FDA) has announced the approval of Omnaris (ciclesonide) nasal spray, a new drug for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis, commonly known as hay fever, in adults and children 12 years of age and older.

23 Oct 2006

Four die following flu vaccination

Following the death of four men who had been inoculated against flu, Israeli authorities have suspended nationwide flu vaccinations.

23 Oct 2006

New York State Court of Appeals upholds contraceptive coverage law

The New York State Court of Appeals on Thursday voted 6-0 to uphold rulings by the New York Supreme Court and the Appellate Division to leave intact a state law that requires employers -- including the Roman Catholic Church and other religious organizations -- who offer prescription drug plans to provide coverage for FDA-approved contraceptives for women, the New York Times reports.

22 Oct 2006

Washington, D.C., to offer caremark Rx discount cards to all residents

Washington, D.C., Mayor Anthony Williams on Wednesday announced a program called DC Rx that will provide prescription drug discount cards at no cost to residents, the Washington Post reports (Silverman, Washington Post, 10/19).

22 Oct 2006

FFTC and FDA act against internet vendors of fraudulent diabetes treatments

The Federal Trade Commission (FTC) and the Food and Drug Administration (FDA), working with government agencies in Mexico and Canada, have launched a drive to stop deceptive Internet advertisements and sales of products misrepresented as cures or treatments for diabetes.

19 Oct 2006

Former FDA Administrator Crawford pleads guilty to conflicts of interest

Lester Crawford, who resigned as FDA commissioner in September 2005, on Tuesday pleaded guilty in U.S. District Court to charges of false reporting and conflicts of interest related to ownership of stocks in companies that are regulated by the agency, the AP/Philadelphia Inquirer reports (Bridges, AP/Philadelphia Inquirer, 10/18).

19 Oct 2006